IFP Advisors’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History

IFP Advisors’s Portfolio NBRV Stock Details NBRV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-28	Closed	-$1K	–	4676
2022 Q4	$1K	Sell	28 -672	-96%	-$1.48K	﹤0.01%	4575
2022 Q3	$1K	Buy	700 +672	+2,400%	+$2.83K	﹤0.01%	4764
2022 Q2	$1K	Hold	28	–	–	﹤0.01%	4531
2022 Q1	$1K	Buy	+28	New	+$340	﹤0.01%	4529
2019 Q4	–	Sell	-1	Closed	-$459	–	3240
2019 Q3	$1K	Buy	+1	New	+$564	﹤0.01%	2986

Other funds holding NBRV

VFA

Values First Advisors Gray, Tennessee $219M AUM 33.32% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

IFP Advisors's NBRV Position: Q1 2023 in Review

IFP Advisors sold out of Nabriva Therapeutics plc Ordinary Shares Ireland (NBRV) in Q1 2023, closing a stake of 28 shares — an estimated $1K sold.

IFP Advisors first reported a position in NBRV in Q3 2019 and held it in 5 quarters. The position peaked at $1K in Q4 2022. 12 funds tracked by Wall St. Rank hold NBRV as of Q1 2023.

IFP Advisors reported no remaining Nabriva Therapeutics plc Ordinary Shares Ireland position as of Q1 2023 after selling out during the quarter.
IFP Advisors sold 28 Nabriva Therapeutics plc Ordinary Shares Ireland shares in Q1 2023, an estimated $1K.
IFP Advisors first reported a position in Nabriva Therapeutics plc Ordinary Shares Ireland in Q3 2019 and held it in 5 quarters.
IFP Advisors's Nabriva Therapeutics plc Ordinary Shares Ireland position peaked at $1K in Q4 2022.
12 funds tracked by Wall St. Rank held Nabriva Therapeutics plc Ordinary Shares Ireland as of Q1 2023.

Based on IFP Advisors's 13F filing for Q1 2023, filed 18 Apr 2023.